esomeprazole 40 mg

ApprovedCompleted
0 views this week 0 watching Active
Interest: 43/100
43
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

Heartburn

Conditions

Heartburn

Trial Timeline

Nov 1, 2010 → Jun 1, 2011

About esomeprazole 40 mg

esomeprazole 40 mg is a approved stage product being developed by AstraZeneca for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT01249651. Target conditions include Heartburn.

What happened to similar drugs?

6 of 14 similar drugs in Heartburn were approved

Approved (6) Terminated (0) Active (8)

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT01249651ApprovedCompleted
NCT00734097ApprovedCompleted